Safety Trial of Naproxen Sodium/ Diphenhydramine

Completed · Phase 3 · Has a placebo group

Conditions studied: Pain

In brief

The purpose of this trial is to see how safe the combination of naproxen sodium 440 mg and diphenhydramine hydrochloride (DPH) 50 mg (the investigational product) is compared to placebo (capsules containing no drug) when taken for 10 days.

Key facts

Study ID
NCT01365052
Run by
Bayer
People needed
326
Starts
2011-05-01
Expected to finish
2011-07-01
Last updated by the study team
2015-06-08

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.